FDA Inspection
Nesher Pharmaceuticals (USA) LLCNesher Pharmaceuticals (USA) LLC – FDA Inspection, Jul 18, 2018
Record Details
This FDA Inspection record concerns Nesher Pharmaceuticals (USA) LLC, with an inspection on July 18, 2018, issued by the Kansas City District Office, covering human drugs.
- People
- Andrew J. Idzior (FDA Associated Person)
- Michele Perry-Williams (FDA Associated Person)
- Yaodong Huang (Issuing Officer)
View Company Profile
ID · c8bdf7cc-e8fc-4139-9071-21dd98d763c6
Inspection Facts
- Inspection number
- 1059731
- FDA center
- Human Drugs
- Outcome
- Form 483 issued
Other FDA inspections of Nesher Pharmaceuticals (USA) LLC
10| Date | Classification | Office | Project area |
|---|---|---|---|
| August 12, 2021 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 31, 2019 | OAI | Kansas City District Office | Generic Drug Evaluation |
| May 31, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| January 11, 2018 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| February 3, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Nesher Pharmaceuticals (USA) LLC
- FDA Inspection 1151199 - 2021-08-12
- FDA Inspection 1098358 - 2019-07-31
- FDA Inspection 1092585 - 2019-05-31
- FDA Inspection 1040785 - 2018-01-11
- FDA Inspection 1002473 - 2017-02-03
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.